# Carrie Ye

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/carrie-ye/

## Facts

| Field | Value |
| --- | --- |
| Citations | 859 |
| Field | Cancer Immunotherapy and Biomarkers |
| h-index | 14 |
| i10-index | 21 |
| Last Known Institution | University of Alberta |
| OpenAlex ID | https://openalex.org/A5051152466 |
| ORCID iD | 0000-0002-9858-5398 |
| Works | 86 |

## Researcher papers

- [Preexisting autoimmune disease and immune-related adverse events associated with anti-PD-1 cancer immunotherapy: a national case series from the Canadian Research Group of Rheumatology in Immuno-Oncology](https://scholariq.org/papers/preexisting-autoimmune-disease-and-immune-related-adverse-events-associated-with/)
- [Immune-related Adverse Events Associated with Cancer Immunotherapy: A Review for the Practicing Rheumatologist](https://scholariq.org/papers/immune-related-adverse-events-associated-with-cancer-immunotherapy-a-review-for/)
- [Rheumatic immune-related adverse events associated with cancer immunotherapy: A nationwide multi-center cohort](https://scholariq.org/papers/rheumatic-immune-related-adverse-events-associated-with-cancer-immunotherapy-a/)
- [Hydroxychloroquine is a safe and effective steroid-sparing agent for immune checkpoint inhibitor–induced inflammatory arthritis](https://scholariq.org/papers/hydroxychloroquine-is-a-safe-and-effective-steroid-sparing-agent-for-immune/)
- [Doctor Versus Artificial Intelligence: Patient and Physician Evaluation of Large Language Model Responses to Rheumatology Patient Questions in a <scp>Cross‐Sectional</scp> Study](https://scholariq.org/papers/doctor-versus-artificial-intelligence-patient-and-physician-evaluation-of-large/)
- [Persistence and adherence to parenteral osteoporosis therapies: a systematic review](https://scholariq.org/papers/persistence-and-adherence-to-parenteral-osteoporosis-therapies-a-systematic/)
- [Osteoporosis](https://scholariq.org/papers/osteoporosis/)
- [Fulminant Viral Hepatitis](https://scholariq.org/papers/fulminant-viral-hepatitis/)
- [Fracture risk and assessment in adults with cancer](https://scholariq.org/papers/fracture-risk-and-assessment-in-adults-with-cancer/)
- [Fracture rate increases after immune checkpoint inhibitor treatment: a potential new immune related adverse event](https://scholariq.org/papers/fracture-rate-increases-after-immune-checkpoint-inhibitor-treatment-a-potential/)
- [Adoption and perception of LLM-based chatbots in health care: an exploratory cross-sectional survey of individuals with rheumatic diseases](https://scholariq.org/papers/adoption-and-perception-of-llm-based-chatbots-in-health-care-an-exploratory/)

## Researcher topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Bone health and osteoporosis research](https://scholariq.org/topics/bone-health-and-osteoporosis-research/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [Bone health and treatments](https://scholariq.org/topics/bone-health-and-treatments/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)

## Researcher university

- [University of Alberta](https://scholariq.org/institutions/university-of-alberta/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.